Results 41 to 50 of about 111,421 (336)

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma [PDF]

, 2015
Author version made available in accordance with publisher policy.Abstract Background The poor prognosis and rising incidence of esophageal adenocarcinoma highlight the need for improved detection methods.
Bowen, Joanne M, Bright, Tim Flaxman, Chiam, Karen, Hussey, Damian James, Irivine, Tanya, Jones, Michael E, Keefe, Dorothy M K, Mayne, George C, Smith, Lorelle, Thompson, Sarah K, Wang, Tingting, Watson, David Ian, White, Imogen A   +12 more
core   +1 more source

Clinical biomarkers in esophageal adenocarcinoma

Frontiers in Bioscience, 2010
This review describes genetic and molecular changes related to adenocarcinoma of the esophagus and gastroesophageal junction (GEJ) with emphasis on prognostic value and possibilities for targeted therapy in clinical setting. The progression of Barrett's esophagus to adenocarcinoma has been the focus of particular scrutiny, and a number of potential ...
BIONDI, Antonio Giuseppe, MIGLIORE, Marcello, STRANO G, VADALA S, TROPEA A, BASILE, Francesco   +5 more
openaire   +5 more sources

Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis

Thoracic Cancer, 2020
Background Recent studies have indicated that the incidence of esophageal cancer has declined in the past decade in the U.S. However, trends in the incidence and survival have not been thoroughly examined.
Haiqi He, Nanzheng Chen, Yue Hou, Zhe Wang, Yong Zhang, Guangjian Zhang, Junke Fu   +6 more
doaj   +1 more source

Recent developments in esophageal adenocarcinoma [PDF]

CA: A Cancer Journal for Clinicians, 2013
AbstractAnswer questions and earn CME/CNEEsophageal adenocarcinoma (EAC) is characterized by 6 striking features: increasing incidence, male predominance, lack of preventive measures, opportunities for early detection, demanding surgical therapy and care, and poor prognosis.
Lagergren, Jesper, Lagergren, Pernilla
openaire   +4 more sources

Nonsurgical Management of Esophageal Adenocarcinoma

Clinical Colorectal Cancer, 2011
The benefit of induction chemotherapy (IC) before chemoradiotherapy (CRT) for inoperable esophageal adenocarcinoma has not been established. To clarify toxicities and outcomes of combined modality treatment, we performed a retrospective review.Sixty-eight consecutive patients were identified. Fifty-one patients had CRT, 17 had radiotherapy (RT).
Gujral, D, Hawkins, M, Leonulli, BG, Ashley, S, Chau, I, Cunningham, D, Tait, D   +6 more
openaire   +4 more sources

Recurrence of intestinal metaplasia and early neoplasia after endoscopic eradication therapy for Barrett’s esophagus: A systematic review and meta-analysis [PDF]

, 2017
Background Conflicting data exist with regard to recurrence rates of intestinal metaplasia (IM) and dysplasia after achieving complete eradication of intestinal metaplasia (CE-IM) in Barrett’s esophagus (BE) patients.
Cinnor, Birtukan, Das, Ananya, Early, Dayna S, Edmundowicz, Steven A, Fujii-Lau, Larissa L, Gaddam, Srinivas, Komanduri, Srinadh, Kushnir, Vladimir, Mullady, Daniel, Muthusamy, V. Raman, Shaheen, Nicholas, Simon, Violette C, Wani, Sachin, Wilson, Robert   +13 more
core   +2 more sources

Antioxidant, cytotoxicity, anti-human esophageal squamous cell carcinoma, anti-human Caucasian esophageal carcinoma, anti-adenocarcinoma of the gastroesophageal junction, and anti-distal esophageal adenocarcinoma properties of gold nanoparticles green synthesized by Rhus coriaria L. fruit aqueous extract

Journal of Experimental Nanoscience, 2020
Every year, many people die due to cancer in all of the world. So, the preparation and formulation of new chemotherapeutic supplements and drugs with remarkable effects for the treatment of cancer are in the priority of both developing and developed ...
Jin Liu, Akram Zangeneh, Mohammad Mahdi Zangeneh, Baohu Guo   +3 more
doaj   +1 more source

Delayed bronchial obstruction following esophageal stent placement: A case report and review of the literature

Radiology Case Reports, 2023
Esophageal adenocarcinoma typically has a poor prognosis at the time of diagnosis. Consequently, palliation of symptoms is vital to disease management with a cornerstone for palliation being esophageal stent placement.
Seth Arntz, BSc, Luke Roller, MD
doaj   +1 more source

An investigation of the progression from Barrett's esophagus to adenocarcinoma [PDF]

, 2016
Barrett's esophagus is a metaplasia of the epithelium of the lower esophagus from a normal squamous appearance to a columnar appearance more typically found in the stomach. It is normally caused by prolonged gastric reflux. While Barrett's esophagus is
Palmese, Scott Joseph
core   +1 more source

Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis [PDF]

, 2014
Oesophageal adenocarcinoma (EAC) incidence is rapidly increasing in Western countries. A better understanding of EAC underpins efforts to improve early detection and treatment outcomes.
Anderson, M, Bailey, P, Barbour, A, Bruxner, T, Campbell, P, Christ, A, Fink, J, Gotley, D, Grimmond, S, Harliwong, I, Hayward, N, Holmes, O, Hussey, D, Idrisoglu, S, Kazakoff, S, Krause, L, Lampe, G, Leonard, C, Loffler, K, Lord, R, Manning, S, Miller, D, Nancarrow, D, Newell, F, Nones, K, Nourbakhsh, E, Nourse, C, Patch, A, Pearson, J, Phillips, W, Quek, K, Quinn, M, Reid, L, Simpson, P, Smithers, B, Tang, Y, Waddell, N, Waddell, N, Watson, D, Wayte, N, Whiteman, D, Wilson, P, Wood, S, Xu, Q   +43 more
core   +4 more sources